Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

398 ARTÍCULOS , VIENDO DEL 196 AL 210

Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease

Jia L, Piña-Crespo J, Li Y.

Mol Brain. 2019 Dec 4;12(1):104. doi: 10.1186/s13041-019-0525-5.

[Alzheimer's disease and singing: an application in mediated therapy]

Hamm S, Sudres JL, Menouer L, Brandibas G.

Soins Gerontol. 2019 Nov-Dec;24(140):15-19. doi: 10.1016/j.sger.2019.09.004.

[Mobile applications in alzheimer's disease. A systematic review of the literature]

Sánchez-Gutiérrez C, Ortega-Bastidas P, Cano-de-la-Cuerda R.

Rehabilitacion (Madr). 2019 Oct-Dec;53(4):247-275. doi: 10.1016/j.rh.2019.07.002. Epub 2019 Nov 18.

Rhinorrhea as a Result of Alzheimer's Disease Treatment: A Case Report

Bartlett D, Bear M.

Sr Care Pharm. 2019 Dec 1;34(10):669-673. doi: 10.4140/TCP.n.2019.669.

An overview of glutaminyl cyclase inhibitors for Alzheimer's disease

Coimbra JR, Sobral PJ, Santos AE, Moreira PI, Salvador JA.

Future Med Chem. 2019 Dec;11(24):3179-3194. doi: 10.4155/fmc-2019-0163.

Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement

Stanciu GD, Luca A, Rusu RN, Bild V, Beschea Chiriac SI, Solcan C, Bild W, Ababei DC.

Biomolecules. 2019 Dec 26;10(1):40. doi: 10.3390/biom10010040.

Cost of Treatment and Care for People with Alzheimer's Disease: A Meta- Analysis

Marešová P, Dolejs J, Mohelska H, Bryan LK.

Curr Alzheimer Res. 2019;16(14):1245-1253. doi: 10.2174/1567205017666200102144640.

Therapeutic Study of Phytochemicals Against Cancer and Alzheimer's Disease Management

Ahmad SS, Waheed T, Rozeen S, Mahmood S, Kamal MA.

Curr Drug Metab. 2019;20(13):1006-1013. doi: 10.2174/1389200221666200103092719.

Neuroprotective Effects of Quercetin in Alzheimer's Disease

Khan H, Ullah H, Aschner M, Cheang WS, Akkol EK.

Biomolecules. 2019 Dec 30;10(1):59. doi: 10.3390/biom10010059.

Misfolded proteins as a therapeutic target in Alzheimer's disease

Liyanage SI, Weaver DF.

Adv Protein Chem Struct Biol. 2019;118:371-411. doi: 10.1016/bs.apcsb.2019.08.003. Epub 2019 Sep 21.

Challenges in the Discovery of Novel Therapeutic Agents in Cancer

Nagaraju GP, Kamal MA.

Curr Drug Metab. 2019;20(13):1004-1005. doi: 10.2174/138920022013200123122311.

Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study

Chris Min K, Dockendorf MF, Palcza J, Tseng J, Ma L, Stone JA, Kleijn HJ, Hodsman P, Masuo K, Tanen M, Troyer MD, van Vugt M, Forman MS.

Clin Pharmacol Ther. 2019 May;105(5):1234-1243. doi: 10.1002/cpt.1258. Epub 2019 Jan 18.

A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan

Chang CC, Peng GS, Lai TJ, Li CH, Liu CK.

Adv Ther. 2019 Jun;36(6):1455-1464. doi: 10.1007/s12325-019-00939-0. Epub 2019 Apr 5.

Mediterranean and MIND Diets Containing Olive Biophenols Reduces the Prevalence of Alzheimer's Disease

Omar SH.

Int J Mol Sci. 2019 Jun 7;20(11):2797. doi: 10.3390/ijms20112797.

Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer's disease

Kalamägi J, Lavikainen P, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM.

Ann Med. 2019 Aug-Sep;51(5-6):294-305. doi: 10.1080/07853890.2019.1642507. Epub 2019 Aug 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias